MDCC Molecular Devices (MM)

Molecular Devices Introduces SpectraMax(R) M5 Multi-Detection Microplate Reader System SUNNYVALE, Calif., Oct. 25 /PRNewswire-FirstCall/ -- Molecular Devices Corporation (NASDAQ:MDCC) today announced the introduction of SpectraMax(R) M5, a five-mode multi-detection microplate reader system, and the latest addition to the company's popular SpectraMax product line. The system has primary applications for fluorescence intensity, absorbance, luminescence, Time-Resolved Fluorescence (TRF) and Fluorescence Polarization (FP) assays, and will debut today at Neuroscience 2004 in San Diego, California. The SpectraMax M5 will allow life science and drug discovery researchers to increase their productivity by giving them multiple detection modes in one powerful, compact instrument. The SpectraMax M5 features a triple-mode cuvette port and a single-read command capability for experiments requiring multiple detection parameters. The system also gives users the flexibility to choose wavelengths between 200 nm and 1000 nm. The SpectraMax M5 uses standard microplates to read endpoint, kinetic, spectrum, multi-wavelength and well-area scanning. For life sciences research, the system is well suited for ELISA, nucleic acid, protein quantitation, enzymatic, cell viability and proliferation assays. Kinase, reporter gene, FRET and other homogeneous and heterogeneous assays can also be run. Commenting on the launch, Stephen J. Oldfield, Ph.D., Molecular Devices' Vice President of Worldwide Marketing, stated, "The SpectraMax M5 has optical performance which is comparable to our dedicated, top-of-the-line readers for all five of its primary detection modes. With its broad assay capability, this system can be used as a research tool to optimize assays in early ADME or quality control, or used as a screening instrument." He further stated, "When the SpectraMax M5 is integrated with our SynchroMax(TM) ET plate handling robot, up to 320 plates can be run without interruption, with multiple assay parameters on each plate." SpectraMax M5 utilizes SoftMax(R) Pro Enterprise software, the industry- leading data acquisition and analysis software with FDA 21 CFR Part 11 compliance tools. Molecular Devices Corporation is a leading supplier of high-performance bioanalytical measurement systems that accelerate and improve drug discovery and other life sciences research. The Company's systems and consumables enable pharmaceutical and biotechnology companies to leverage advances in genomics, proteomics and combinatorial chemistry by facilitating the high- throughput and cost-effective identification and evaluation of drug candidates. The Company's solutions are based on its advanced core technologies that integrate its expertise in engineering, molecular and cell biology and chemistry. Molecular Devices enables its customers to improve research productivity and effectiveness, which ultimately accelerates the complex process of discovering and developing new drugs. This press release contains "forward-looking" statements, including statements related to the prospects for or potential customer use of the SpectraMax(R) M5. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Words such as "believes," "anticipates," "plans," "expects," "will," and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause the results of Molecular Devices Corporation to differ materially from those indicated by these forward-looking statements, including, among others, risks related to the development of new products and other risks detailed from time to time in the Company's SEC reports, including its Annual Report on Form 10-K for the year ended December 31, 2003, as amended, and its Quarterly Report on Form 10-Q for the quarter ended June 30, 2004. Molecular Devices Corporation does not undertake any obligation to update forward-looking statements. DATASOURCE: Molecular Devices Corporation CONTACT: Tim Harkness of Molecular Devices Corporation, +1-408-747-3533 Web site: http://www.moleculardevices.com/

Copyright